| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $19.0M | +41.5% |
| SG&A Expense | $11.5M | +79.9% |
| Operating Income | -$30.5M | -53.8% |
| Interest Expense | $883K | +0.0% |
| Net Income | -$30.3M | -39.3% |
| EPS (Basic) | -$0.92 | +0.0% |
| EPS (Diluted) | -$0.91 | +1.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.8M | -39.1% |
| Short-term Investments | $15.9M | +0.0% |
| Current Assets | $11.6M | -66.8% |
| Total Assets | $13.2M | -63.5% |
| Current Liabilities | $5.0M | +54.7% |
| Total Liabilities | $5.3M | +50.7% |
| Stockholders' Equity | $7.9M | -75.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.9M | -53.9% |
| Capital Expenditures | $105K | -81.4% |
| Investing Cash Flow | $15.7M | +194.2% |
| Financing Cash Flow | $2.3M | -95.0% |
| Free Cash Flow | -$25.0M | -49.3% |